DrStockPick.com Stock Report! 9/14/09, BSI, NFRX, TEVE, NIMU, PER
DrStockPick.com Stock Report!
Monday September 14, 2009
**************************************************************
Blue Square-Israel Ltd. (NYSE: BSI) announced that it was served with a claim and a request for approval as a class action (the “Claim”), in which Blue Square is being sued regarding the sale of cosmetics and perfume products without marking the expiry date or the allowed use period after its opening, as is allegedly obligatory according to the 15 amendment of the Pharmacists directive [new edition] 1981 which is in effect since July 1st 2009.
InferX Corporation (Pink Sheets: NFRX) today announced that it has signed a Memoradum of Understanding (MOU) with KG Information Systems Limited (KGiSL) part of KG Group of companies to develop solutions powered by InferX products and market to its client base in the Banking, Financial Services and Insurance (BFSI) and Healthcare sectors in the United States, India and globally.
TelVue Corporation (OTCBB:TEVE) announced the release of version 3.6 of their TelVue Princeton(TM) digital broadcast server software. According to TelVue, the version 3.6 software release contains significant improvements and several new integrated workflow features that will assist community and hyperlocal television stations maximize the value of their TelVue Princeton(TM) broadcast server.
Marvin A Sackner, M.D., Chief Executive Officer of Non-Invasive Monitoring Systems, Inc. [NIMS] (OTCBB:NIMU) announced that Drs. Miyamoto, Fujita and others from Osaka and Kyoto, Japan presented a paper entitled “Novel treatment with whole body periodic acceleration with a horizontal motion platform improves exercise capacity, myocardial ischemia and left ventricular function” at the European Society of Cardiology (ESC) Congress in Barcelona on September 1, 2009. The Exer-Rest(R) patented technology was utilized to apply non-invasive whole body periodic acceleration [WBPA] for 45 minutes a day, 5 days a week for four weeks, a total of 20 treatments. A small dose of intravenous heparin was administered 10 to 20 minutes prior to each WBPA treatment. Thirteen patients, mean age 69 years, with advanced coronary artery disease, chronic effort angina and reduced cardiac function as measured by an ejection fraction that averaged 35% constituted the treatment group. Another 13 patients with the same characteristics, mean age 66 years, remained sedentary throughout a four week period as a control group.
Perot Systems Corporation (NYSE: PER) today announced that it will conduct a free webinar Wednesday, September 16, from 2:00-3:00 pm (CDT) on Health Information Exchanges (HIEs), providing an industry perspective and highlighting recent activities and trends. The webinar will help healthcare leaders and state officials better understand how to establish and evolve HIEs. The webinar will be hosted by Tim Quigley and Dave Marchand, leaders in the Perot Systems Healthcare group.
***********Advertisement***********
********************************
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) .Rule 17B requires disclosure of payment for investor relations.
